Stem Cell Differentiation via Density and Marker Selection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for regulating stem cell migration and differentiation are inefficient and lack control over specific cell type production, limiting their therapeutic applications in regenerative medicine.
Innovation Solution
A method involving the processing of a core cell population (CCP) with specific density and marker characteristics, such as CD34+CD45−/Dim and CD31Bright cells, to stimulate differentiation into progenitor/precursor cell populations through co-culture with target tissues and use of stimulation factors, enabling the production of desired cell types like endothelial, neural, or cardiac cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If spontaneous differentiation is allowed in embryoid bodies, then stem cell cultures remain healthy and can form multiple cell types, but the efficiency of producing specific cell types is low
Solution Approach 1:
The patent applies parameter changes by modifying the chemical composition of the culture medium, including specific growth factors, hormones, and signaling molecules, to direct stem cell differentiation toward desired cell types while maintaining culture health and productivity
2Productivity
If chemical composition of culture medium is altered to control stem cell differentiation, then specific cell types can be produced, but the process complexity increases
Solution Approach 1:
The patent applies preliminary action by pre-preparing and optimizing culture medium formulations with specific chemical compositions before stem cell differentiation, allowing controlled production of specific cell types without increasing operational complexity during the differentiation process
Data Source
AI summary
Provided are methods for producing progenitor/precursor cells from a population of initiating cells (ICP) that have a density of less than 1.072 g/ml and at least 25% of which are CD31Bright by in vitro stimulating the ICP with different factors.